AdvisorShares Psychedelics ETF
PSIL
14 hedge funds and large institutions have $308K invested in AdvisorShares Psychedelics ETF in 2025 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 1 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 1
51% more capital invested
Capital invested by funds: $204K → $308K (+$104K)
0.45% more ownership
Funds ownership: 2.53% → 2.98% (+0.45%)
0% more funds holding
Funds holding: 14 → 14 (0)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CIBC Private Wealth Group
Atlanta,
Georgia
|
+$46K |
| 2 |
SWM
Spire Wealth Management
Mclean,
Virginia
|
+$25 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$4.06K |
| 2 |
NECFA
New England Capital Financial Advisors
Meriden,
Connecticut
|
-$392 |
PSIL Hedge Fund Activity: Q2 2025 in Review
14 of the 7,611 institutional investors tracked by Wall St. Rank reported a position in AdvisorShares Psychedelics ETF (PSIL) for Q2 2025, worth a combined $308K — up 51% from $204K a quarter earlier.
Fund positioning in PSIL was balanced in Q2 2025: 1 fund opened new positions, 1 closed out, 2 added to existing stakes and 1 trimmed.
The largest buyer was CIBC Private Wealth Group, adding an estimated $46K. The largest seller was UBS Group, cutting an estimated $4.06K.
- 14 institutional investors held AdvisorShares Psychedelics ETF (PSIL) as of Q2 2025, unchanged from Q1 2025.
- Funds reported $308K of AdvisorShares Psychedelics ETF stock for Q2 2025, up 51% quarter-over-quarter.
- 1 fund opened new AdvisorShares Psychedelics ETF positions in Q2 2025 and 1 closed out, a net change of 0 holders.
- The largest AdvisorShares Psychedelics ETF buyer in Q2 2025 was CIBC Private Wealth Group, an estimated $46K added.
- The largest AdvisorShares Psychedelics ETF seller in Q2 2025 was UBS Group, an estimated $4.06K sold.
Based on aggregated 13F filings for Q2 2025.